Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Exacerbation of Psychosis”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Testing effectiveness (Phase 2)Study completedNCT01234779
What this trial is testing

RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 301
Testing effectiveness (Phase 2)Study completedNCT02477020
What this trial is testing

Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Takeda 164
Testing effectiveness (Phase 2)Ended earlyNCT00412620
What this trial is testing

An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia

Who this might be right for
Schizophrenia
Abbott 156
Testing effectiveness (Phase 2)Study completedNCT00404573
What this trial is testing

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 375
Large-scale testing (Phase 3)Study completedNCT01098110
What this trial is testing

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124)

Who this might be right for
Schizophrenia
Organon and Co 532
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Large-scale testing (Phase 3)Ended earlyNCT00645229
What this trial is testing

The Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1
Testing effectiveness (Phase 2)Ended earlyNCT00570063
What this trial is testing

Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo

Who this might be right for
Schizophrenia
Pfizer 35
Large-scale testing (Phase 3)Study completedNCT03345979
What this trial is testing

Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 200
Post-approval studies (Phase 4)Study completedNCT00644800
What this trial is testing

The Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis

Who this might be right for
SchizophreniaManiaDelusional Disorder+1 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 89
Testing effectiveness (Phase 2)Study completedNCT00265551
What this trial is testing

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 300
Large-scale testing (Phase 3)Study completedNCT00151424
What this trial is testing

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)

Who this might be right for
Schizophrenia
Organon and Co 277
Large-scale testing (Phase 3)Study completedNCT00334126
What this trial is testing

Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 399
Testing effectiveness (Phase 2)Study completedNCT05227690
What this trial is testing

A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 385
Large-scale testing (Phase 3)Study completedNCT02634346
What this trial is testing

ALKS 3831 in Adults With Acute Exacerbation of Schizophrenia (the ENLIGHTEN-1 Study)

Who this might be right for
Schizophrenia
Alkermes, Inc. 403
Testing effectiveness (Phase 2)Study completedNCT01490086
What this trial is testing

RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder

Who this might be right for
Acute SchizophreniaSchizoaffective Disorder
Reviva Pharmaceuticals 234
Testing effectiveness (Phase 2)WithdrawnNCT00988728
What this trial is testing

Efficacy & Safety of SCH 900435 in Schizophrenia (Study P06079)(WITHDRAWN)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07038876
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia

Who this might be right for
Schizophrenia
MapLight Therapeutics 300
Testing effectiveness (Phase 2)Study completedNCT01175135
What this trial is testing

An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 259
Testing effectiveness (Phase 2)Study completedNCT04512066
What this trial is testing

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 287
Load More Results